Neurotrophic signaling cascades are major long-term targets for lithium: Clinical implications

Clinical Neuroscience Research

Volumn 4, Issue 3-4 SPEC. ISS., 2004, Pages 137-153

  Yuan, Peixiong ^a   Gould, Todd D ^a   Gray, Neil A ^a   Bachmann, Rosilla F ^a   Schloesser, Robert J ^a   Lan, Martin J K ^a   Du, Jing ^a   Moore, Gregory J ^b   Manji, Husseini K ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Brain; Huntington's disease; Lithium; Manic depressive illness; Mood stabilizer; Neuroprotection; Psychopharmacology; Stroke

Indexed keywords

2 (2,4 DICHLOROPHENYL) 3 (1 METHYL 3 INDOLYL)MALEIMIDE; FRAT 1; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 INHIBITOR; INDIRUBIN; LITHIUM; MITOGEN ACTIVATED PROTEIN KINASE; N ACETYLASPARTIC ACID; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL 2; PROTEIN KINASE B; UNCLASSIFIED DRUG; VALPROIC ACID;

ALZHEIMER DISEASE; APOPTOSIS; BRAIN NERVE CELL; BRAIN SIZE; CENTRAL NERVOUS SYSTEM; CHRONIC DRUG ADMINISTRATION; DEGENERATIVE DISEASE; DISEASE SEVERITY; DRUG MECHANISM; DRUG TARGETING; EVIDENCE BASED MEDICINE; GENE EXPRESSION REGULATION; GLIA CELL; GRAY MATTER; HUMAN; HUNTINGTON CHOREA; MITOCHONDRION; MOOD DISORDER; MORPHOMETRICS; NERVE CELL CULTURE; NERVE CELL GROWTH; NERVE CELL PLASTICITY; NEUROPROTECTION; NONHUMAN; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SIGNAL TRANSDUCTION; STROKE;

EID: 13344278678     PISSN: 15662772     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cnr.2004.09.006     Document Type: Article

References (142)

1. T.E. Bates M. Strangward J. Keelan G.P. Davey P.M. Munro J.B. Clark Inhibition of N-acetylaspartate production: Implications for 1H MRS studies in vivo Neuroreport 7 1996 1397-1400
2. G. Tsai J.T. Coyle N-acetylaspartate in neuropsychiatric disorders Prog Neurobiol 46 1995 531-540
3. C. Dautry F. Vaufrey E. Brouillet et al. Early N-acetylaspartate depletion is a marker of neuronal dysfunction in rats and primates chronically treated with the mitochondrial toxin 3-nitropropionic acid J Cereb Blood Flow Metab 20 2000 789-799
4. A. Bertolino M. Frye J.H. Callicott et al. Neuronal pathology in the hippocampal area of patients with bipolar disorder: A study with proton magnetic resonance spectroscopic imaging Biol Psychiatry 53 2003 906-913
5. R.F. Deicken M.P. Pegues S. Anzalone R. Feiwell B. Soher Lower concentration of hippocampal N-acetylaspartate in familial bipolar I disorder Am J Psychiatry 160 2003 873-882
6. M.E. Winsberg N. Sachs D.L. Tate E. Adalsteinsson D. Spielman T.A. Ketter Decreased dorsolateral prefrontal N-acetyl aspartate in bipolar disorder Biol Psychiatry 47 2000 475-481
7. K.M. Cecil M.P. DelBello R. Morey S.M. Strakowski Frontal lobe differences in bipolar disorder as determined by proton MR spectroscopy Bipolar Disord 4 2002 357-365
8. K. Chang N. Adleman K. Dienes N. Barnea-Goraly A. Reiss T. Ketter Decreased N-acetylaspartate in children with familial bipolar disorder Biol Psychiatry 53 2003 1059-1065
9. H. Hamakawa T. Kato J. Murashita N. Kato Quantitative proton magnetic resonance spectroscopy of the basal ganglia in patients with affective disorders Eur Arch Psychiatry Clin Neurosci 248 1998 53-58
10. R.H. Lenox T.D. Gould H.K. Manji Endophenotypes in bipolar disorder Am J Med Genet 114 2002 391-406
11. L.L. Altshuler J.G. Curran P. Hauser J. Mintz K. Denicoff R. Post T2 hyperintensities in bipolar disorder: Magnetic resonance imaging comparison and literature meta-analysis Am J Psychiatry 152 1995 1139-1144
12. C.E. Bearden K.M. Hoffman T.D. Cannon The neuropsychology and neuroanatomy of bipolar affective disorder: A critical review Bipolar Disord 3 2001 106-150 discussion 151-3
13. A.L. Stoll P.F. Renshaw D.A. Yurgelun-Todd B.M. Cohen Neuroimaging in bipolar disorder: What have we learned? Biol Psychiatry 48 2000 505-517
14. A.J. Thomas J.T. O'Brien S. Davis et al. Ischemic basis for deep white matter hyperintensities in major depression: A neuropathological study Arch Gen Psychiatry 59 2002 785-792
15. I.K. Lyoo H.K. Lee J.H. Jung G.G. Noam P.F. Renshaw White matter hyperintensities on magnetic resonance imaging of the brain in children with psychiatric disorders Compr Psychiatry 43 2002 361-368
16. J.J. Pillai L. Friedman T.A. Stuve et al. Increased presence of white matter hyperintensities in adolescent patients with bipolar disorder Psychiatry Res 114 2002 51-56
17. T. Kato J. Murashita A. Kamiya T. Shioiri N. Kato T. Inubushi Decreased brain intracellular pH measured by 31P-MRS in bipolar disorder: A confirmation in drug-free patients and correlation with white matter hyperintensity Eur Arch Psychiatry Clin Neurosci 248 1998 301-306
18. W.C. Drevets Neuroimaging studies of mood disorders Biol Psychiatry 48 2000 813-829
19. W.C. Drevets Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders Curr Opin Neurobiol 11 2001 240-249
20. G. Rajkowska Cell pathology in mood disorders Semin Clin Neuropsychiatry 7 2002 281-292
21. D. Ongur W.C. Drevets J.L. Price Glial reduction in the subgenual prefrontal cortex in mood disorders Proc Natl Acad Sci USA 95 1998 13290-13295
22. H.K. Manji J.A. Quiroz J. Sporn et al. Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression Biol Psychiatry 53 2003 707-742
23. L.D. Selemon G. Rajkowska Two-dimensional versus three-dimensional cell counting Biol Psychiatry 51 2002 838-840 reply 842-6
24. F.M. Benes E.W. Kwok S.L. Vincent M.S. Todtenkopf A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives Biol Psychiatry 44 1998 88-97
25. G. Rajkowska Histopathology of the prefrontal cortex in major depression: What does it tell us about dysfunctional monoaminergic circuits? Prog Brain Res 126 2000 397-412
26. H.K. Manji J.A. Quiroz J. Sporn et al. Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression Biol Psychiatry 53 2003 707-742
27. R.M. Sapolsky Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders Arch Gen Psychiatry 57 2000 925-935
28. B.S. McEwen Stress and hippocampal plasticity Annu Rev Neurosci 22 1999 105-122
29. R.M. Sapolsky The possibility of neurotoxicity in the hippocampus in major depression: A primer on neuron death Biol Psychiatry 48 2000 755-765
30. M.A. Smith S. Makino R. Kvetnansky R.M. Post Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus J Neurosci 15 1995 1768-1777
31. M. Nibuya M. Takahashi D.S. Russell R.S. Duman Repeated stress increases catalytic TrkB mRNA in rat hippocampus Neurosci Lett 267 1999 81-84
32. L.A. Mamounas M.E. Blue J.A. Siuciak C.A. Altar Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain J Neurosci 15 1995 7929-7939
33. M.D. Jacobson M. Weil M.C. Raff Programmed cell death in animal development Cell 88 1997 347-354
34. B. Pettmann C.E. Henderson Neuronal cell death Neuron 20 1998 633-647
35. H. Thoenen Neurotrophins and neuronal plasticity Science 270 1995 593-598
36. R.A. Segal M.E. Greenberg Intracellular signaling pathways activated by neurotrophic factors Annu Rev Neurosci 19 1996 463-489
37. 2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism Neuron 20 1998 709-726
38. A. Riccio S. Ahn C.M. Davenport J.A. Blendy D.D. Ginty Mediation by a CREB family transcription factor of NGF-dependent survival of sympathetic neurons Science 286 1999 2358-2361
39. A. Bonni A. Brunet A.E. West S.R. Datta M.A. Takasu M.E. Greenberg Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms Science 286 1999 1358-1362
40. D.F. Chen S. Tonegawa Why do mature CNS neurons of mammals fail to re-establish connections following injury-functions of bcl-2 Cell Death Differ 5 1998 816-822
41. D.F. Chen G.E. Schneider J.C. Martinou S. Tonegawa Bcl-2 promotes regeneration of severed axons in mammalian CNS Nature 385 1997 434-439
42. K.H. Holm F. Cicchetti L. Bjorklund et al. Enhanced axonal growth from fetal human bcl-2 transgenic mouse dopamine neurons transplanted to the adult rat striatum Neuroscience 104 2001 397-405
43. Y.J. Oh B.C. Swarzenski K.L. O'Malley Overexpression of Bcl-2 in a murine dopaminergic neuronal cell line leads to neurite outgrowth Neurosci Lett 202 1996 161-164
44. S. Chierzi E. Strettoi M.C. Cenni L. Maffei Optic nerve crush: Axonal responses in wild-type and bcl-2 transgenic mice J Neurosci 19 1999 8367-8376
45. A.C. DeVries H.D. Joh O. Bernard et al. Social stress exacerbates stroke outcome by suppressing Bcl-2 expression Proc Natl Acad Sci USA 98 2001 11824-11828
46. P.X. Yuan L.D. Huang Y.M. Jiang J.S. Gutkind H.K. Manji G. Chen The mood stabilizer valproic acid activates mitogen-activated protein kinases and promotes neurite growth J Biol Chem 276 2001 31674-31683
47. H. Einat P. Yuan T.D. Gould et al. The role of the extracellular signal-regulated kinase signaling pathway in mood modulation J Neurosci 23 2003 7311-7316
48. H. Einat H.K. Manji T.D. Gould J. Du G. Chen Possible involvement of the ERK signaling cascade in bipolar disorder: Behavioral leads from the study of mutant mice Drug News Perspect 16 2003 453-463
49. G. Chen W.Z. Zeng P.X. Yuan et al. The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS J Neurochem 72 1999 879-882
50. H.K. Manji G.J. Moore G. Chen Lithium at 50: Have the neuroprotective effects of this unique cation been overlooked? Biol Psychiatry 46 1999 929-940
51. H.K. Manji G.J. Moore G. Chen Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo: A role for neurotrophic and neuroprotective effects in manic depressive illness J Clin Psychiatry 61 Suppl. 9 2000 82-96
52. H.K. Manji G.J. Moore G. Chen Clinical and preclinical evidence for the neurotrophic effects of mood stabilizers: Implications for the pathophysiology and treatment of manic-depressive illness Biol Psychiatry 48 2000 740-754
53. R.W. Chen D.M. Chuang Long term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression. A prominent role in neuroprotection against excitotoxicity J Biol Chem 274 1999 6039-6042
54. R. Lu L. Song R.S. Jope Lithium attenuates p53 levels in human neuroblastoma SH-SY5Y cells Neuroreport 10 1999 1123-1125
55. X. Huang D.Y. Wu G. Chen H. Manji D.F. Chen Support of retinal ganglion cell survival and axon regeneration by lithium through a Bcl-2-dependent mechanism Invest Ophthalmol Vis Sci 44 2003 347-354
56. H. Dudek S.R. Datta T.F. Franke et al. Regulation of neuronal survival by the serine-threonine protein kinase Akt Science 275 1997 661-665
57. E. Chalecka-Franaszek D.M. Chuang Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons Proc Natl Acad Sci USA 96 1999 8745-8750
58. A. Mora G. Sabio A.M. Risco et al. Lithium blocks the PKB and GSK3 dephosphorylation induced by ceramide through protein phosphatase-2A Cell Signal 14 2002 557-562
59. J.M. Beaulieu T.D. Sotnikova W.D. Yao et al. Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade Proc Natl Acad Sci USA 2004
60. S. Finkbeiner CREB couples neurotrophin signals to survival messages Neuron 25 2000 11-14
61. K.L. Kopnisky E. Chalecka-Franaszek M. Gonzalez-Zulueta D.M. Chuang Chronic lithium treatment antagonizes glutamate-induced decrease of phosphorylated CREB in neurons via reducing protein phosphatase 1 and increasing MEK activities Neuroscience 116 2003 425-35
62. W.G. Tatton R.M. Chalmers-Redman Mitochondria in neurodegenerative apoptosis: An opportunity for therapy? Ann Neurol 44 1998 S134-S41
63. A.M. Palmer P.M. Greengrass D. Cavalla The role of mitochondria in apoptosis Drug News Perspect 13 2000 378-84
64. A.M. Gorman S. Ceccatelli S. Orrenius Role of mitochondria in neuronal apoptosis Dev Neurosci 22 2000 348-58
65. L. Colombaioni L. Colombini M. Garcia-Gil Role of mitochondria in serum withdrawal-induced apoptosis of immortalized neuronal precursors Brain Res Dev Brain Res 134 2002 93-102
66. S. Raha B.H. Robinson Mitochondria, oxygen free radicals, and apoptosis Am J Med Genet 106 2001 62-70
67. Q. Chen Y. Chai S. Mazuder J. Drazba G. Chisolm A. Almasan The late increase of free radicals during genotoxic-stress induced apoptosis is associated with cytochrome C release from mitochondria induced by Caspase-mediated feedback loop amplification Scientific World J 1 2001 142
68. P. Parone M. Priault D. James S.F. Nothwehr J.C. Martinou Apoptosis: bombarding the mitochondria Essays Biochem 39 2003 41-51
69. T. Kuwana D.D. Newmeyer Bcl-2-family proteins and the role of mitochondria in apoptosis Curr Opin Cell Biol 15 2003 691-9
70. B. Antonsson Mitochondria and the Bcl-2 family proteins in apoptosis signaling pathways Mol Cell Biochem 256-257 2004 141-55
71. A. Gross BCL-2 proteins: Regulators of the mitochondrial apoptotic program IUBMB Life 52 2001 231-6
72. H.G. Wang S. Takayama U.R. Rapp J.C. Reed Bcl-2 interacting protein, BAG-1, binds to and activates the kinase Raf-1 Proc Natl Acad Sci USA 93 1996 7063-8
73. W. Elyaman F. Terro K.C. Suen C. Yardin R.C. Chang J. Hugon BAD and Bcl-2 regulation are early events linking neuronal endoplasmic reticulum stress to mitochondria-mediated apoptosis Brain Res Mol Brain Res 109 2002 233-8
74. O. Ghribi M.M. Herman N.K. Spaulding J. Savory Lithium inhibits aluminum-induced apoptosis in rabbit hippocampus, by preventing cytochrome c translocation, Bcl-2 decrease, Bax elevation and caspase-3 activation J Neurochem 82 2002 137-45
75. D.M. Chuang R.W. Chen E. Chalecka-Franaszek et al. Neuroprotective effects of lithium in cultured cells and animal models of diseases Bipolar Disord 4 2002 129-36
76. G.N. Bijur R.S. Jope Glycogen synthase kinase-3 beta is highly activated in nuclei and mitochondria Neuroreport 14 2003 2415-9
77. M. Hoshi A. Takashima K. Noguchi et al. Regulation of mitochondrial pyruvate dehydrogenase activity by tau protein kinase I/glycogen synthase kinase 3beta in brain Proc Natl Acad Sci USA 93 1996 2719-23
78. P. Watcharasit G.N. Bijur L. Song J. Zhu X. Chen R.S. Jope Glycogen synthase kinase-3beta (GSK3beta) binds to and promotes the actions of p53 J Biol Chem 278 2003 48872-9
79. P. Watcharasit G.N. Bijur J.W. Zmijewski et al. Direct, activating interaction between glycogen synthase kinase-3beta and p53 after DNA damage Proc Natl Acad Sci USA 99 2002 7951-5
80. M. Mihara S. Erster A. Zaika et al. p53 has a direct apoptogenic role at the mitochondria Mol Cell 11 2003 577-90
81. P. Dumont J.I. Leu A.C. Della Pietra 3rd D.L. George M. Murphy The codon 72 polymorphic variants of p53 have markedly different apoptotic potential Nat Genet 33 2003 357-65
82. C. Sansome A. Zaika N.D. Marchenko U.M. Moll Hypoxia death stimulus induces translocation of p53 protein to mitochondria. Detection by immunofluorescence on whole cells FEBS Lett 488 2001 110-5
83. N.D. Marchenko A. Zaika U.M. Moll Death signal-induced localization of p53 protein to mitochondria. A potential role in apoptotic signaling J Biol Chem 275 2000 16202-12
84. T.D. King G.N. Bijur R.S. Jope Caspase-3 activation induced by inhibition of mitochondrial complex I is facilitated by glycogen synthase kinase-3beta and attenuated by lithium Brain Res 919 2001 106-14
85. G.N. Bijur R.S. Jope Rapid accumulation of Akt in mitochondria following phosphatidylinositol 3-kinase activation J Neurochem 87 2003 1427-35
86. M. Pap G.M. Cooper Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-Kinase/Akt cell survival pathway J Biol Chem 273 1998 19929-32
87. G.I. Welsh C.M. Miller A.J. Loughlin N.T. Price C.G. Proud Regulation of eukaryotic initiation factor eIF2B: Glycogen synthase kinase-3 phosphorylates a conserved serine which undergoes dephosphorylation in response to insulin FEBS Lett 421 1998 125-30
88. H.R. Cock The role of mitochondria and oxidative stress in neuronal damage after brief and prolonged seizures Prog Brain Res 135 2002 187-96
89. 2+)-induced membrane permeability transition in brain mitochondria J Neurochem 79 2001 1237-45
90. A. Atlante P. Calissano A. Bobba S. Giannattasio E. Marra S. Passarella Glutamate neurotoxicity, oxidative stress and mitochondria FEBS Lett 497 2001 1-5
91. M. Schafer S. Goodenough B. Moosmann C. Behl Inhibition of glycogen synthase kinase 3beta is involved in the resistance to oxidative stress in neuronal HT22 cells Brain Res 1005 2004 84-9
92. A.N. Murphy D.E. Bredesen G. Cortopassi E. Wang G. Fiskum Bcl-2 potentiates the maximal calcium uptake capacity of neural cell mitochondria Proc Natl Acad Sci USA 93 1996 9893-8
93. S. Nonaka C.J. Hough D.M. Chuang Chronic lithium treatment robustly protects neurons in the central nervous system against excitotoxicity by inhibiting N-methyl- d -aspartate receptor-mediated calcium influx Proc Natl Acad Sci USA 95 1998 2642-7
94. W.P. Tseng S.Y. Lin-Shiau Long-term lithium treatment prevents neurotoxic effects of beta-bungarotoxin in primary cultured neurons J Neurosci Res 69 2002 633-41
95. S.R. D'Mello R. Anelli P. Calissano Lithium induces apoptosis in immature cerebellar granule cells but promotes survival of mature neurons Exp Cell Res 211 1994 332-8
96. R. Li D.M. Chuang R.J. Wyatt D.G. Kirch Effect of chronic haloperidol treatment on dopamine-induced inositol phosphate formation in rat brain slices Neurochem Res 19 1994 673-8
97. M. Inouye H. Yamamura A. Nakano Lithium delays the radiation-induced apoptotic process in external granule cells of mouse cerebellum J Radiat Res (Tokyo) 36 1995 203-8
98. T. Pascual J.L. Gonzalez A protective effect of lithium on rat behaviour altered by ibotenic acid lesions of the basal forebrain cholinergic system Brain Res 695 1995 289-92
99. S. Grignon N. Levy F. Couraud B. Bruguerolle Tyrosine kinase inhibitors and cycloheximide inhibit Li+protection of cerebellar granule neurons switched to non-depolarizing medium Eur J Pharmacol 315 1996 111-4
100. R. Hashimoto C. Hough T. Nakazawa T. Yamamoto D.M. Chuang Lithium protection against glutamate excitotoxicity in rat cerebral cortical neurons: Involvement of NMDA receptor inhibition possibly by decreasing NR2B tyrosine phosphorylation J Neurochem 80 2002 589-97
101. R. Hashimoto K. Fujimaki M.R. Jeong L. Christ D.M. Chuang Lithium-induced inhibition of Src tyrosine kinase in rat cerebral cortical neurons: A role in neuroprotection against N-methyl- d -aspartate receptor-mediated excitotoxicity FEBS Lett 538 2003 145-148
102. A. Mora R.A. Gonzalez-Polo J.M. Fuentes G. Soler F. Centeno Different mechanisms of protection against apoptosis by valproate and Li+ Eur J Biochem 266 1999 886-891
103. F. Centeno A. Mora J.M. Fuentes G. Soler E. Claro Partial lithium-associated protection against apoptosis induced by C2-ceramide in cerebellar granule neurons Neuroreport 9 1998 4199-4203
104. E. Jorda E. Verdaguer A. Morano et al. Lithium prevents colchicine-induced apoptosis in rat cerebellar granule neurons Bipolar Disord 6 2004 144-149
105. S. Nonaka N. Katsube D.M. Chuang Lithium protects rat cerebellar granule cells against apoptosis induced by anticonvulsants, phenytoin and carbamazepine J Pharmacol Exp Ther 286 1998 539-547
106. J.P. Hennion M.A. el-Masri M.O. Huff R.S. el-Mailakh Evaluation of neuroprotection by lithium and valproic acid against ouabain-induced cell damage Bipolar Disord 4 2002 201-206
107. L. Song P. De Sarno R.S. Jope Central role of glycogen synthase kinase-3beta in endoplasmic reticulum stress-induced caspase-3 activation J Biol Chem 277 2002 44701-44708
108. H. Cimarosti R. Rodnight A. Tavares et al. An investigation of the neuroprotective effect of lithium in organotypic slice cultures of rat hippocampus exposed to oxygen and glucose deprivation Neurosci Lett 315 2001 33-36
109. S.B. Maggirwar N. Tong S. Ramirez H.A. Gelbard S. Dewhurst HIV-1 Tat-mediated activation of glycogen synthase kinase-3beta contributes to Tat-mediated neurotoxicity J Neurochem 73 1999 578-586
110. C.L. Wellington B.R. Leavitt M.R. Hayden Huntington disease: New insights on the role of huntingtin cleavage J Neural Transm Suppl 2000 1-17
111. J. Carmichael K.L. Sugars Y.P. Bao D.C. Rubinsztein Glycogen synthase kinase-3beta inhibitors prevent cellular polyglutamine toxicity caused by the Huntington's disease mutation J Biol Chem 277 2002 33791-33798
112. M. Perez A.I. Rojo F. Wandosell J. Diaz-Nido J. Avila Prion peptide induces neuronal cell death through a pathway involving glycogen synthase kinase 3 Biochem J 372 2003 129-136
113. G. Alvarez J.R. Munoz-Montano J. Satrustegui J. Avila E. Bogonez J. Diaz-Nido Lithium protects cultured neurons against beta-amyloid-induced neurodegeneration FEBS Lett 453 1999 260-264
114. Y. Zhang Y. Hong Y. Bounhar et al. p75 neurotrophin receptor protects primary cultures of human neurons against extracellular amyloid beta peptide cytotoxicity J Neurosci 23 2003 7385-7394
115. G.N. Bijur P. De Sarno R.S. Jope Glycogen synthase kinase-3beta facilitates staurosporine- and heat shock-induced apoptosis. Protection by lithium J Biol Chem 275 2000 7583-7590
116. V. Hongisto N. Smeds S. Brecht T. Herdegen M.J. Courtney E.T. Coffey Lithium blocks the c-Jun stress response and protects neurons via its action on glycogen synthase kinase 3 Mol Cell Biol 23 2003 6027-6036
117. M. Sparapani M. Virgili F. Ortali A. Contestabile Effects of chronic lithium treatment on ornithine decarboxylase induction and excitotoxic neuropathology in the rat Brain Res 765 1997 164-168
118. S. Nonaka D.M. Chuang Neuroprotective effects of chronic lithium on focal cerebral ischemia in rats Neuroreport 9 1998 2081-2084
119. G. Chen G. Rajkowska F. Du N. Seraji-Bozorgzad H.K. Manji Enhancement of hippocampal neurogenesis by lithium J Neurochem 75 2000 1729-1734
120. M. Ren V.V. Senatorov R.W. Chen D.M. Chuang Postinsult treatment with lithium reduces brain damage and facilitates neurological recovery in a rat ischemia/reperfusion model Proc Natl Acad Sci USA 100 2003 6210-6215
121. M.F. Beal N.W. Kowall D.W. Ellison M.F. Mazurek K.J. Swartz J.B. Martin Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid Nature 321 1986 168-171
122. H. Wei Z.H. Qin V.V. Senatorov et al. Lithium suppresses excitotoxicity-induced striatal lesions in a rat model of Huntington's disease Neuroscience 106 2001 603-612
123. I.P. Everall C. Bell M. Mallory et al. Lithium ameliorates HIV-gp120-mediated neurotoxicity Mol Cell Neurosci 21 2002 493-501
124. G.E. Wood L.T. Young L.P. Reagan B. Chen B.S. McEwen Stress-induced structural remodeling in hippocampus: Prevention by lithium treatment Proc Natl Acad Sci USA 101 2004 3973-3978
125. A.E. Willing T. Zigova M. Milliken et al. Lithium exposure enhances survival of NT2N cells (hNT neurons) in the hemiparkinsonian rat Eur J Neurosci 16 2002 2271-2278
126. M.P. Bowley W.C. Drevets D. Ongur J.L. Price Low glial numbers in the amygdala in major depressive disorder Biol Psychiatry 52 2002 404-412
127. G.J. Moore J.M. Bebchuk K. Hasanat et al. Lithium increases N-acetyl-aspartate in the human brain: In vivo evidence in support of bcl-2's neurotrophic effects? Biol Psychiatry 48 2000 1-8
128. G.J. Moore J.M. Bebchuk I.B. Wilds G. Chen H.K. Manji H.K. Menji Lithium-induced increase in human brain grey matter Lancet 356 2000 1241-1242
129. N.A. Gray R. Zhou J. Du G.J. Moore H.K. Manji The use of mood stabilizers as plasticity enhancers in the treatment of neuropsychiatric disorders J Clin Psychiatry 64 Suppl. 5 2003 3-17
130. Y.I. Sheline M. Sanghavi M.A. Mintun M.H. Gado Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression J Neurosci 19 1999 5034-5043
131. S.M. Strakowski D.R. Wilson M. Tohen B.T. Woods A.W. Douglass A.L. Stoll Structural brain abnormalities in first-episode mania Biol Psychiatry 33 1993 602-609
132. Y. Hirayasu M.E. Shenton D.F. Salisbury et al. Subgenual cingulate cortex volume in first-episode psychosis Am J Psychiatry 156 1999 1091-1093
133. G.E. Berger S. Wood P.D. McGorry Incipient neurovulnerability and neuroprotection in early psychosis Psychopharmacol Bull 37 2003 79-101
134. E.J. Nestler Antidepressant treatments in the 21st century Biol Psychiatry 44 1998 526-533
135. R. Li R.S. El-Mallahk A novel evidence of different mechanisms of lithium and valproate neuroprotective action on human SY5Y neuroblastoma cells: Caspase-3 dependency Neurosci Lett 294 2000 147-150
136. H.K. Manji R.H. Lenox Signaling: Cellular insights into the pathophysiology of bipolar disorder Biol Psychiatry 48 2000 518-530
137. T.D. Gould C.A. Zarate H.K. Manji Glycogen synthase kinase-3: A target for novel bipolar disorder treatments J Clin Psychiatry 65 2004 10-21
138. G. Manfredi J.Q. Kwong J.A. Oca-Cossio et al. BCL-2 improves oxidative phosphorylation and modulates adenine nucleotide translocation in mitochondria of cells harboring mutant mtDNA J Biol Chem 278 2003 5639-5645
139. J.B. Schulz D. Bremen J.C. Reed et al. Cooperative interception of neuronal apoptosis by BCL-2 and BAG-1 expression: Prevention of caspase activation and reduced production of reactive oxygen species J Neurochem 69 1997 2075-2086
140. S. Shimizu Y. Eguchi W. Kamiike et al. Bcl-2 prevents apoptotic mitochondrial dysfunction by regulating proton flux Proc Natl Acad Sci USA 95 1998 1455-1459
141. A.J. Kowaltowski R.G. Cosso C.B. Campos G. Fiskum Effect of Bcl-2 overexpression on mitochondrial structure and function J Biol Chem 277 2002 42802-42807
142. Soares JC. Contributions from brain imaging to the elucidation of pathophysiology of bipolar disorder Int J Neuropsychopharmacol 2003;6:171-80